LQDA logo

Liquidia Corporation (LQDA)

$56.73

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on LQDA

Market cap

$5.11B

EPS

-1.2

P/E ratio

--

Price to sales

5.44

Dividend yield

8.987%

Beta

0.378683

Price on LQDA

Previous close

$56.37

Today's open

$56.49

Day's range

$54.80 - $57.21

52 week range

$22.31 - $93.61

Profile about LQDA

CEO

Roger A. Jeffs

Employees

216

Headquarters

Morrisville, NC

Exchange

NASDAQ Capital Market

Shares outstanding

90106442

Issue type

Common Stock

LQDA industries and sectors

Healthcare

Biotechnology & Life Sciences

News on LQDA

Liquidia: Yutrepia's PAH Franchise Has Room To Grow

Liquidia kept the right to market YUTREPIA for PAH after the settlement with United Therapeutics. This settlement limits YUTREPIA's potential in PH-ILD, but since it can still be sold to patients using it and to patients with PAH, Liquidia Corporation can continue generating revenue. YUTREPIA is already generating cash. Paid PAH starts will show how much of the lost PH-ILD growth LQDA can replace.

news source

Seeking Alpha • Nov 14, 2026

news preview

LQDA Q3 Earnings Call Highlights Growth and Post-Settlement Outlook

Liquidia reports surging YUTREPIA sales, record October shipments and expanding PAH adoption amid post-settlement market changes and referral disruptions.

news source

Zacks Investment Research • Nov 11, 2026

news preview

LQDA Q3 Earnings Beat Estimates on Robust Yutrepia Sales

Liquidia's Q3 earnings and revenues beat estimates as Yutrepia sales surge, while strong PAH demand and pipeline investments support growth.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Liquidia Q3 Earnings Call Highlights

Liquidia NASDAQ: LQDA reported a 31% sequential increase in third-quarter YUTREPIA sales as the company sought to reassure investors that its pulmonary arterial hypertension business can continue growing following a patent settlement with United Therapeutics.

news source

MarketBeat • Nov 10, 2026

news preview

Liquidia Corporation (LQDA) Q3 2026 Earnings Call Transcript

Liquidia Corporation (LQDA) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

Liquidia Corporation Reports Third Quarter 2026 Financial Results

MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today reported financial results for the third quarter ended September 30, 2026. The company will also host a webcast at 8:30 a.m. ET on November 10, 2026, to discuss its financial results and provide a corporate update.

news source

GlobeNewsWire • Nov 10, 2026

news preview

Liquidia Corporation (LQDA) Q3 Earnings and Revenues Beat Estimates

Liquidia Corporation (LQDA) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to a loss of $0.04 per share a year ago.

news source

Zacks Investment Research • Nov 10, 2026

news preview

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company's business in a fireside chat at the 2026 Jefferies Global Healthcare Conference, Tuesday, November 17, at 10 a.m.

news source

GlobeNewsWire • Nov 10, 2026

news preview

Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026

MORRISVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its third quarter 2026 financial results on Tuesday, November 10, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update.

news source

GlobeNewsWire • Nov 3, 2026

news preview

Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?

LQDA's Q3 results will spotlight the impact of its legal settlement with UTHR, cash flow pressures, profitability prospects and pipeline progress.

news source

Zacks Investment Research • Oct 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Liquidia Corporation

Open an M1 investment account to buy and sell Liquidia Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in LQDA on M1